HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies.

AbstractBACKGROUND:
Among adipokines and hepatokines, adiponectin and fetuin-A were consistently found to predict the incidence of type 2 diabetes, both by regulating insulin sensitivity.
OBJECTIVE:
To determine to what extent circulating adiponectin and fetuin-A are independently associated with incident type 2 diabetes in humans, and the major mechanisms involved.
METHODS:
Relationships with incident diabetes were tested in two cohort studies: within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study (628 cases) and the Nurses' Health Study (NHS; 470 cases). Relationships with body fat compartments, insulin sensitivity and insulin secretion were studied in the Tübingen Lifestyle Intervention Program (TULIP; N = 358).
RESULTS:
Circulating adiponectin and fetuin-A, independently of several confounders and of each other, associated with risk of diabetes in EPIC-Potsdam (RR for 1 SD: adiponectin: 0.45 [95% CI 0.37-0.54], fetuin-A: 1.18 [1.05-1.32]) and the NHS (0.51 [0.42-0.62], 1.35 [1.16-1.58]). Obesity measures considerably attenuated the association of adiponectin, but not of fetuin-A. Subjects with low adiponectin and concomitantly high fetuin-A had the highest risk. Whereas both proteins were independently (both p<1.8×10(-7)) associated with insulin sensitivity, circulating fetuin-A (r = -0.37, p = 0.0004), but not adiponectin, associated with insulin secretion in subjects with impaired glucose tolerance.
CONCLUSIONS:
We provide novel information that adiponectin and fetuin-A independently of each other associate with the diabetes risk. Furthermore, we suggest that they are involved in the development of type 2 diabetes via different mechanisms, possibly by mediating effects of their source tissues, expanded adipose tissue and nonalcoholic fatty liver.
AuthorsNorbert Stefan, Qi Sun, Andreas Fritsche, Jürgen Machann, Fritz Schick, Felicia Gerst, Charlotte Jeppesen, Hans-Georg Joost, Frank B Hu, Heiner Boeing, Susanne Ullrich, Hans-Ulrich Häring, Matthias B Schulze
JournalPloS one (PLoS One) Vol. 9 Issue 3 Pg. e92238 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID24643166 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • ADIPOQ protein, human
  • Adiponectin
  • Biomarkers
  • alpha-2-HS-Glycoprotein
Topics
  • Adiponectin (blood)
  • Adult
  • Aged
  • Biomarkers (blood)
  • Body Mass Index
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 (blood)
  • Female
  • Glucose Intolerance (blood)
  • Humans
  • Insulin Resistance
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Phenotype
  • Prospective Studies
  • Risk
  • Waist Circumference
  • alpha-2-HS-Glycoprotein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: